This inventor holds 2 USPTO granted patents. Top assignee: Syntex (u.s.a.) Inc.. Active years: 2002-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2003
Title: Ian Edward David Smith: Innovator in Pharmaceutical Chemistry
Introduction
Ian Edward David Smith is a notable inventor based in Bedfordshire, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 2 patents to his name, Smith's work has garnered attention in the scientific community.
Latest Patents
Smith's latest patents include innovative compounds such as alkylamino-substituted bicyclic nitrogen heterocycles. These compounds are recognized for their potential as inhibitors of p38, a critical target in various inflammatory diseases. Additionally, he has developed alkylamino-substituted dihydropyrimido[4,5-d]pyrimidinone derivatives, which are also useful in pharmaceutical preparations.
Career Highlights
Ian Edward David Smith is currently associated with Syntex (U.S.A.) Inc., where he continues to advance his research in pharmaceutical innovations. His work focuses on creating effective therapeutic agents that can address unmet medical needs.
Collaborations
Throughout his career, Smith has collaborated with esteemed colleagues, including David Michael Goldstein and William Harris. These partnerships have contributed to the successful development of his patented inventions.
Conclusion
Ian Edward David Smith stands out as a dedicated inventor in the pharmaceutical industry, with a focus on creating innovative compounds that hold promise for future medical applications. His contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile